Europe Chinese Hamster Ovary Cells Cho Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 104,656.51 Thousand |
 Market Size (Forecast Year) |
USD 190,312.23 Thousand |
 CAGR |
% |
| Major Markets Players |
>欧洲中国仓鼠卵巢 (CHO) 细胞市场，按类型（服务和产品）、系统（代谢选择系统、抗生素选择系统等）、应用（生物制剂和医学研究）、最终用户（生物制药公司、生物技术公司、临床开发和制造组织、临床研究组织、学术机构和研究组织等）、分销渠道（直接招标、零售销售等）划分 - 行业趋势和预测到 2030 年。
欧洲中国仓鼠卵巢 (CHO) 细胞市场分析与洞察
欧洲中国仓鼠卵巢 (CHO) 细胞市场是生物制药行业的重要组成部分，受生物制剂和治疗性蛋白质需求不断增长的推动。CHO 细胞是生物制药生产的首选，因为它们能够有效表达具有适当翻译后修饰的复杂蛋白质。
Data Bridge Market Research 分析称，欧洲中国仓鼠卵巢 (CHO) 细胞市场规模预计将从 2022 年的 104,656.51 万美元增至 2030 年的 190,312.23 万美元，在 2023 年至 2030 年的预测期内，复合年增长率将达到 8.2%。
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021 (可定制为 2015-2020) |
|
定量单位 |
收入（千美元）、平均售价（美元）和销量（千美元） |
|
涵盖的领域 |
类型（服务和产品）、系统（代谢选择系统、抗生素选择系统等）、应用（生物制剂和医学研究）、最终用户（生物制药公司、生物技术公司、临床开发和制造组织、临床研究组织、学术机构和研究组织等）、分销渠道（直接招标、零售等） |
|
覆盖国家 |
德国、英国、法国、俄罗斯、意大利、西班牙、土耳其、波兰、比利时、荷兰、瑞士、丹麦、瑞典、挪威、芬兰和欧洲其他地区 |
|
涵盖的市场参与者 |
Abeomics、AcceGen、Applied Biological Materials Inc. (abm)、ATCC、BPS Bioscience, Inc.、CLS Cell Lines Service GmbH、Curia Global, Inc.、Cytiva、GenTarget Inc.、GTP Bioways、Horizon Discovery Ltd.、Lonza、Merck KGaA、Promega Corporation、RayBiotech Life, Inc.、Sartorius AG、Thermo Fisher Scientific Inc. 等 |
市场定义
中国仓鼠卵巢 (CHO) 细胞是一种哺乳动物细胞系，常用于生物技术和生物医学研究，特别是在细胞培养和生物加工领域。这些细胞已成为生物技术和生物医学研究中必不可少的工具。CHO 细胞以其对培养表面的粘附性、强劲的生长特性和表达重组蛋白的能力而闻名。它们之所以受欢迎，是因为它们与人类细胞相似，适合研究生物过程和生产生物制药。
欧洲中国仓鼠卵巢 (CHO) 细胞市场动态
本节旨在了解市场驱动因素、机遇、限制和挑战。以下内容将详细讨论所有这些内容：
驱动程序
- CHO 细胞在遗传研究中的应用日益广泛
CHO 细胞因其在基因操作和表达系统中的适应性和多功能性而在遗传研究中占据了重要地位。欧洲各地的研究人员和生物技术专家越来越依赖 CHO 细胞来研究遗传学的各个方面，包括基因表达、基因组编辑和功能基因组学。
CHO 细胞为基因研究提供了一个稳定且特征明确的平台，使其成为了解基因功能、蛋白质表达和开发新治疗剂的重要资源。人们对使用 CHO 细胞进行基因研究的兴趣日益浓厚，这不仅刺激了对 CHO 细胞的需求，还推动了生物技术和基因工程技术的创新。因此，该市场正在经历增长，因为它满足了从事基因研究和生物技术的科学界日益增长的需求，进一步巩固了其在生命科学领域的地位。
- 生物制药需求不断增长
CHO 细胞在单克隆抗体、疫苗和治疗性蛋白质等生物制药的生产中发挥着至关重要的作用。随着欧洲人口老龄化和医疗保健需求的增加，对这些先进药物的需求不断增加。CHO 细胞为大规模生物制药生产提供了可靠而高效的平台，使其成为生物制造过程中不可或缺的一部分。随着制药公司和生物技术公司寻求满足对创新疗法和疫苗的需求，该市场正在稳步增长，加强了其在生物制药行业的关键作用。
克制
- CHO 细胞生产成本高
CHO 细胞生产的高成本严重制约了市场的增长，因为这个成本因素可能会限制 CHO 细胞技术在生物制药生产的广泛应用，影响欧洲市场生物制药的可负担性和可及性。
机会
-
细胞培养技术的不断发展
细胞培养技术的不断进步促进了生物制药生产的生产力、可扩展性和成本效益的提高，为市场增长创造了良好的机会。
挑战
- CHO 细胞系开发过程耗时且不一致
开发用于生物制药生产的稳定高产 CHO 细胞系可能是一项耗时且资源密集的工作。细胞系性能和特性的变化可能导致生产不可预测，从而影响生物制药制造的整体效率和成本效益。
优化和鉴定细胞系、选择合适的克隆以及实现一致的生产力水平的需求可能会延长开发时间并增加运营成本。这一挑战不仅影响新生物制药的上市时间，还增加了法规遵从性和质量保证工作的复杂性。因此，解决 CHO 细胞系开发过程耗时且不一致的性质对于提高生物制药行业的市场竞争力至关重要。
最新动态
- 2023 年 7 月，Lonza 推出了 TheraPRO CHO 培养基系统，这是一种新型细胞培养基，在使用 GS-CHO 细胞系时可简化流程并优化生产力和蛋白质质量。这家初创公司支持生产治疗性蛋白质的制药和生物技术公司进一步提高产品质量。TheraPRO CHO 培养基系统性能高效，在 15 天的培养期内可实现高浓度的活细胞和高于 5 g/L 的蛋白质滴度。这相当于使用市售解决方案可生产的蛋白质滴度的两倍以上。此次发布帮助该公司扩大了其在市场上的产品组合。
- 2023 年 7 月，默克集团宣布将扩建位于美国堪萨斯州莱尼克萨的工厂，增加 9,100 平方米的实验室空间和生产细胞培养基的生产能力。此次扩建使莱尼克萨成为该公司最大的干粉细胞培养设施和北美卓越中心。对该地区的投资反映了该公司扩大和多样化供应链的战略，以满足当前和未来对细胞培养平台的需求。
- 2023 年 6 月，领先的合同研究、开发和制造公司 Curia Global, Inc. 宣布已与北美生命科学公司 Millipore Sigma、德国达姆施塔特的 Merck KGaA 签署了许可协议，该协议将允许 Curia 及其客户使用 CHOZN GS-/- 细胞系生产用于治疗目的的蛋白质和抗体。根据协议，CHOZN GS-/- 细胞系将整合到 Curia 的细胞系开发工作流程中，并立即可供 Curia 的客户使用。
- 2022 年 11 月，全球领先的生物材料监管和标准组织 ATCC 宣布推出一系列新的 CAR-T 靶向荧光素酶报告细胞系，以支持免疫肿瘤学 (IO) 发现和新免疫疗法的开发。这些模型具有相关嵌合抗原受体 (CAR) T 靶抗原（如 HER2、CD19 和 CD20）的高内源性表达。这些新的 IO 工具包括表达荧光素酶报告基因的血液癌症和实体瘤细胞系。这有助于该公司扩大其产品组合。
- 2022 年 10 月，赛默飞世尔科技公司与 ProBioGen 合作开发了一个更好的平台，即 Gibco Freedom ExpiCHO-S 细胞系开发试剂盒。该试剂盒允许用户生成适合临床开发的细胞系，而无需自己的原始细胞、载体或该领域的先前经验。ProBioGen 利用其在细胞系和工艺开发方面的强大专业知识，为 Freedom ExpiCHO-S 试剂盒的性能做出了重大贡献。新系列利用赛默飞世尔的 ExpiCHO-S 细胞系，扩大了公司针对 CHO 细胞系开发系列的产品组合。
欧洲中国仓鼠卵巢 (CHO) 细胞市场范围
欧洲中国仓鼠卵巢 (CHO) 细胞市场根据类型、系统、应用、最终用户和分销渠道分为五个显著的细分市场。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
类型
- 服务
- 产品
根据类型，市场分为服务和产品。
系统
- 代谢选择系统
- 抗生素选择系统
- 其他的
根据系统，市场分为代谢选择系统、抗生素选择系统和其他系统。
应用
- 生物制剂
- 医学研究
根据应用，市场分为生物制剂和医学研究。
最终用户
- 生物制药公司
- 生物科技公司
- 临床开发和制造组织
- 临床研究组织
- 学术机构和研究组织
- 其他的
根据最终用户，市场细分为生物制药公司、生物技术公司、临床开发和制造组织、临床研究组织、学术机构和研究组织等。
分销渠道
- 直接招标
- 零售销售
- 其他的
根据分销渠道，市场分为直接招标、零售和其他。
欧洲中国仓鼠卵巢 (CHO) 细胞市场区域分析/见解
欧洲中国仓鼠卵巢 (CHO) 细胞市场根据类型、系统、应用、最终用户和分销渠道分为五个显著的部分。
本市场报告涵盖的国家包括德国、英国、法国、俄罗斯、意大利、西班牙、土耳其、波兰、比利时、荷兰、瑞士、丹麦、瑞典、挪威、芬兰和欧洲其他地区。
由于德国生物制药行业实力强大，专注于创新疗法和疫苗，预计该国将主导欧洲中国仓鼠卵巢 (CHO) 细胞市场，从而增加对生物生产中 CHO 细胞的需求。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测各个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了区域品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战，以及销售渠道的影响。
竞争格局和欧洲中国仓鼠卵巢 (CHO) 细胞市场份额分析
欧洲中国仓鼠卵巢 (CHO) 细胞市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品批准、产品宽度和广度、应用优势和产品类型生命线曲线。以上提供的数据点仅与公司对市场的关注有关。
在欧洲中国仓鼠卵巢 (CHO) 细胞市场运营的一些主要市场参与者包括 Abeomics、AcceGen、Applied Biological Materials Inc. (abm)、ATCC、BPS Bioscience, Inc.、CLS Cell Lines Service GmbH、Curia Global, Inc.、Cytiva、GenTarget Inc.、GTP Bioways、Horizon Discovery Ltd.、Lonza、Merck KGaA、Promega Corporation、RayBiotech Life, Inc.、Sartorius AG、Thermo Fisher Scientific Inc. 等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 BY TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS MODEL
4.2 PORTER'S 5 FORCES
5 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING USE OF CHO CELLS IN THE GENETIC STUDY
6.1.2 GROWING DEMAND FOR BIOPHARMACEUTICALS
6.1.3 RISING INVESTMENTS IN BIOTECHNOLOGY R&D
6.1.4 RISING DEMAND FOR MONOCLONAL ANTIBODIES
6.2 RESTRAINTS
6.2.1 HIGH-COST OF CHO CELL-BASED PRODUCTION
6.2.2 STRICT REGULATORY REQUIREMENTS FOR CHO CELL-BASED PRODUCTION
6.3 OPPORTUNITIES
6.3.1 CONTINUOUS DEVELOPMENT OF CELL CULTURE TECHNOLOGIES
6.3.2 RISING NUMBER OF APPLICATIONS OF CHO CELLS
6.4 CHALLENGES
6.4.1 TIME-CONSUMING AND INCONSISTENCY IN THE CHO CELL LINE DEVELOPMENT PROCESS
6.4.2 CONTAMINATION RISK OF CHO CELL CULTURES
7 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE
7.1 OVERVIEW
7.2 SERVICES
7.3 PRODUCT
7.3.1 CHO-DXB11
7.3.2 CHO-K1
7.3.2.1 CHO-K1 ATCC
7.3.2.2 CHO-K1 ECACC
7.3.2.3 Others
7.3.3 CHO-DG44
7.3.4 CHO-S
7.3.5 OTHERS
8 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM
8.1 OVERVIEW
8.2 METABOLIC SELECTION SYSTEM
8.3 ANTIBIOTIC SELECTION SYSTEM
8.4 OTHERS
9 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 BIOLOGICS
9.2.1 MONOCLONAL ANTIBODIES
9.2.2 ENZYMES
9.2.3 CYTOKINES
9.2.4 CLOTTING FACTORS
9.2.5 HORMONES
9.2.6 FC-FUSION PROTIEN
9.2.7 OTHERS
9.3 MEDICAL RESEARCH
10 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER
10.1 OVERVIEW
10.2 BIOPHARMACEUTICAL COMPANIES
10.2.1 MEDIUM
10.2.2 SMALL
10.3 BIOTECHNOLOGY COMPANIES
10.3.1 MEDIUM
10.3.2 SMALL
10.4 CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS
10.4.1 MEDIUM
10.4.2 SMALL
10.5 CLINICAL RESEARCH ORGANIZATIONS
10.5.1 MEDIUM
10.5.2 SMALL
10.6 ACADEMIC INSTITUTES AND RESEARCH ORGANIZATIONS
10.7 OTHERS
11 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDERS
11.3 RETAIL SALES
11.4 OTHERS
12 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY EUROPE
12.1 EUROPE
12.1.1 GERMANY
12.1.2 U.K.
12.1.3 FRANCE
12.1.4 RUSSIA
12.1.5 ITALY
12.1.6 SPAIN
12.1.7 TURKEY
12.1.8 POLAND
12.1.9 BELGIUM
12.1.10 NETHERLANDS
12.1.11 SWITZERLAND
12.1.12 DENMARK
12.1.13 SWEDEN
12.1.14 NORWAY
12.1.15 FINLAND
12.1.16 REST OF EUROPE
13 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: EUROPE
14 SWOT ANALYSIS
15 COMPANY PROFILES
15.1 SARTORIUS AG
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 PRODUCT PORTFOLIO
15.1.4 RECENT DEVELOPMENT
15.2 LONZA
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 PRODUCT PORTFOLIO
15.2.4 RECENT DEVELOPMENT
15.3 MERCK KGAA
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 PRODUCT PORTFOLIO
15.3.4 RECENT DEVELOPMENT
15.4 CYTIVA
15.4.1 COMPANY SNAPSHOT
15.4.2 PRODUCT PORTFOLIO
15.4.3 RECENT DEVELOPMENT
15.5 THERMO FISHER SCIENTIFIC INC.
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 PRODUCT PORTFOLIO
15.5.4 RECENT DEVELOPMENT
15.6 ABEOMICS
15.6.1 COMPANY SNAPSHOT
15.6.2 PRODUCT PORTFOLIO
15.6.3 RECENT DEVELOPMENT
15.7 ACCEGEN
15.7.1 COMPANY SNAPSHOT
15.7.2 PRODUCT PORTFOLIO
15.7.3 RECENT DEVELOPMENT
15.8 APPLIED BIOLOGICAL MATERIALS INC. (ABM)
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENT
15.9 ATCC
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVELOPMENT
15.1 BPS BIOSCIENCE, INC.
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENT
15.11 CLS CELL LINES SERVICE GMBH
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENT
15.12 CURIA GLOBAL, INC.
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENT
15.13 GENTARGET INC.
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENT
15.14 HORIZON DISCOVERY LTD.
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENT
15.15 PROMEGA CORPORATION
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENT
15.16 RAYBIOTECH LIFE, INC.
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENT
16 QUESTIONNAIRE
17 RELATED REPORTS
表格列表
TABLE 1 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2022-2030 (USD THOUSAND)
TABLE 2 EUROPE PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 3 EUROPE CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 4 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND)
TABLE 5 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 6 EUROPE BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 7 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 8 EUROPE BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 9 EUROPE BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 10 EUROPE CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 11 EUROPE CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 12 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 (USD THOUSAND)
TABLE 13 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)
TABLE 14 GERMANY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 15 GERMANY PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 16 GERMANY PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP
TABLE 17 GERMANY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 18 GERMANY CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 19 GERMANY CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP
TABLE 20 GERMANY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 21 GERMANY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND)
TABLE 22 GERMANY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 23 GERMANY BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 24 GERMANY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 25 GERMANY BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 26 GERMANY BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 27 GERMANY CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 28 GERMANY CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 29 GERMANY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 30 U.K. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 31 U.K. PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 32 U.K. PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP
TABLE 33 U.K. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 34 U.K. CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 35 U.K. CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP
TABLE 36 U.K. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 37 U.K. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND)
TABLE 38 U.K. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 39 U.K. BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 40 U.K. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 41 U.K. BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 42 U.K. BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 43 U.K. CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 44 U.K. CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 45 U.K. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 46 FRANCE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 47 FRANCE PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 48 FRANCE PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP
TABLE 49 FRANCE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 50 FRANCE CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 51 FRANCE CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP
TABLE 52 FRANCE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 53 FRANCE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND)
TABLE 54 FRANCE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 55 FRANCE BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 56 FRANCE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 57 FRANCE BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 58 FRANCE BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 59 FRANCE CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 60 FRANCE CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 61 FRANCE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 62 RUSSIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 63 RUSSIA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 64 RUSSIA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP
TABLE 65 RUSSIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 66 RUSSIA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 67 RUSSIA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP
TABLE 68 RUSSIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 69 RUSSIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND)
TABLE 70 RUSSIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 71 RUSSIA BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 72 RUSSIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 73 RUSSIA BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 74 RUSSIA BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 75 RUSSIA CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 76 RUSSIA CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 77 RUSSIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 78 ITALY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 79 ITALY PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 80 ITALY PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP
TABLE 81 ITALY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 82 ITALY CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 83 ITALY CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP
TABLE 84 ITALY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 85 ITALY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND)
TABLE 86 ITALY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 87 ITALY BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 88 ITALY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 89 ITALY BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 90 ITALY BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 91 ITALY CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 92 ITALY CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 93 ITALY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 94 SPAIN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 95 SPAIN PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 96 SPAIN PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP
TABLE 97 SPAIN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 98 SPAIN CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 99 SPAIN CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP
TABLE 100 SPAIN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 101 SPAIN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND)
TABLE 102 SPAIN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 103 SPAIN BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 104 SPAIN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 105 SPAIN BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 106 SPAIN BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 107 SPAIN CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 108 SPAIN CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 109 SPAIN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 110 TURKEY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 111 TURKEY PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 112 TURKEY PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP
TABLE 113 TURKEY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 114 TURKEY CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 115 TURKEY CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP
TABLE 116 TURKEY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 117 TURKEY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND)
TABLE 118 TURKEY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 119 TURKEY BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 120 TURKEY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 121 TURKEY BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 122 TURKEY BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 123 TURKEY CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 124 TURKEY CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 125 TURKEY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 126 POLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 127 POLAND PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 128 POLAND PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP
TABLE 129 POLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 130 POLAND CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 131 POLAND CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP
TABLE 132 POLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 133 POLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND)
TABLE 134 POLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 135 POLAND BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 136 POLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 137 POLAND BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 138 POLAND BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 139 POLAND CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 140 POLAND CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 141 POLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 142 BELGIUM CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 143 BELGIUM PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 144 BELGIUM PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP
TABLE 145 BELGIUM CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 146 BELGIUM CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 147 BELGIUM CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP
TABLE 148 BELGIUM CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 149 BELGIUM CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND)
TABLE 150 BELGIUM CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 151 BELGIUM BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 152 BELGIUM CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 153 BELGIUM BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 154 BELGIUM BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 155 BELGIUM CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 156 BELGIUM CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 157 BELGIUM CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 158 NETHERLANDS CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 159 NETHERLANDS PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 160 NETHERLANDS PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP
TABLE 161 NETHERLANDS CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 162 NETHERLANDS CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 163 NETHERLANDS CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP
TABLE 164 NETHERLANDS CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 165 NETHERLANDS CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND)
TABLE 166 NETHERLANDS CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 167 NETHERLANDS BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 168 NETHERLANDS CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 169 NETHERLANDS BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 170 NETHERLANDS BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 171 NETHERLANDS CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 172 NETHERLANDS CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 173 NETHERLANDS CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 174 SWITZERLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 175 SWITZERLAND PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 176 SWITZERLAND PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP
TABLE 177 SWITZERLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 178 SWITZERLAND CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 179 SWITZERLAND CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP
TABLE 180 SWITZERLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 181 SWITZERLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND)
TABLE 182 SWITZERLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 183 SWITZERLAND BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 184 SWITZERLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 185 SWITZERLAND BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 186 SWITZERLAND BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 187 SWITZERLAND CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 188 SWITZERLAND CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 189 SWITZERLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 190 DENMARK CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 191 DENMARK PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 192 DENMARK PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP
TABLE 193 DENMARK CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 194 DENMARK CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 195 DENMARK CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP
TABLE 196 DENMARK CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 197 DENMARK CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND)
TABLE 198 DENMARK CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 199 DENMARK BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 200 DENMARK CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 201 DENMARK BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 202 DENMARK BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 203 DENMARK CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 204 DENMARK CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 205 DENMARK CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 206 SWEDEN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 207 SWEDEN PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 208 SWEDEN PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP
TABLE 209 SWEDEN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 210 SWEDEN CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 211 SWEDEN CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP
TABLE 212 SWEDEN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 213 SWEDEN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND)
TABLE 214 SWEDEN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 215 SWEDEN BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 216 SWEDEN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 217 SWEDEN BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 218 SWEDEN BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 219 SWEDEN CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 220 SWEDEN CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 221 SWEDEN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 222 NORWAY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 223 NORWAY PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 224 NORWAY PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP
TABLE 225 NORWAY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 226 NORWAY CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 227 NORWAY CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP
TABLE 228 NORWAY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 229 NORWAY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND)
TABLE 230 NORWAY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 231 NORWAY BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 232 NORWAY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 233 NORWAY BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 234 NORWAY BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 235 NORWAY CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 236 NORWAY CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 237 NORWAY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 238 FINLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 239 FINLAND PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 240 FINLAND PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP
TABLE 241 FINLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 242 FINLAND CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 243 FINLAND CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP
TABLE 244 FINLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 245 FINLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND)
TABLE 246 FINLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 247 FINLAND BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)
TABLE 248 FINLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND)
TABLE 249 FINLAND BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 250 FINLAND BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 251 FINLAND CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 252 FINLAND CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
TABLE 253 FINLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)
TABLE 254 REST OF EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND)
图片列表
FIGURE 1 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: SEGMENTATION
FIGURE 2 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: DROC ANALYSIS
FIGURE 4 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS
FIGURE 5 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: SEGMENTATION
FIGURE 11 GROWING DEMAND FOR BIOPHARMACEUTICALS IS EXPECTED TO DRIVE THE GROWTH OF THE EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET GROWTH IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 12 TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET IN THE FORECAST PERIOD OF 2023 AND 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE CHINESE HAMSTER OVARY CELLS (CHO) MARKET
FIGURE 14 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY TYPE, 2022
FIGURE 15 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY TYPE, 2023-2030 (USD THOUSAND)
FIGURE 16 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY TYPE, CAGR (2023-2030)
FIGURE 17 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY TYPE, LIFELINE CURVE
FIGURE 18 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY SYSTEM, 2022
FIGURE 19 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY SYSTEM, 2023-2030 (USD THOUSAND)
FIGURE 20 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY SYSTEM, CAGR (2023-2030)
FIGURE 21 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY SYSTEM, LIFELINE CURVE
FIGURE 22 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY APPLICATION, 2022
FIGURE 23 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY APPLICATION, 2023-2030 (USD THOUSAND)
FIGURE 24 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 25 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY END USER, 2022
FIGURE 27 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY END USER, 2023-2030 (USD THOUSAND)
FIGURE 28 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY END USER, CAGR (2023-2030)
FIGURE 29 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 31 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD THOUSAND)
FIGURE 32 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 33 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: SNAPSHOT (2022)
FIGURE 35 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: COMPANY SHARE 2022 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
